465
Participants
Start Date
January 31, 2010
Primary Completion Date
October 31, 2010
Study Completion Date
October 31, 2010
insulin degludec/insulin aspart
Treat-to-target dose titration scheme, injected subcutaneously (under the skin) once daily with main meal. Dose was individually adjusted.
insulin glargine
Treat-to-target dose titration scheme, injected subcutaneously (under the skin) once daily. Dose was individually adjusted.
Novo Nordisk Investigational Site, Benoni
Novo Nordisk Investigational Site, Johannesburg
Novo Nordisk Investigational Site, Johannesburg
Novo Nordisk Investigational Site, Albany
Novo Nordisk Investigational Site, Hyattsville
Novo Nordisk Investigational Site, Baltimore
Novo Nordisk Investigational Site, Besançon
Novo Nordisk Investigational Site, Statesville
Novo Nordisk Investigational Site, Atlanta
Novo Nordisk Investigational Site, Jacksonville
Novo Nordisk Investigational Site, Orlando
Novo Nordisk Investigational Site, Pembroke Pines
Novo Nordisk Investigational Site, Boynton Beach
Novo Nordisk Investigational Site, Tampa
Novo Nordisk Investigational Site, Clearwater
Novo Nordisk Investigational Site, Istanbul
Novo Nordisk Investigational Site, Sète
Novo Nordisk Investigational Site, Istanbul
Novo Nordisk Investigational Site, New Port Richey
Novo Nordisk Investigational Site, Istanbul
Novo Nordisk Investigational Site, Istanbul
Novo Nordisk Investigational Site, Kissimmee
Novo Nordisk Investigational Site, Dax
Novo Nordisk Investigational Site, Saint-Herblain
Novo Nordisk Investigational Site, Kahramanmaraş
Novo Nordisk Investigational Site, Southfield
Novo Nordisk Investigational Site, Southfield
Novo Nordisk Investigational Site, Rijeka
Novo Nordisk Investigational Site, Minneapolis
Novo Nordisk Investigational Site, Perpignan
Novo Nordisk Investigational Site, Dallas
Novo Nordisk Investigational Site, Dallas
Novo Nordisk Investigational Site, Paris
Novo Nordisk Investigational Site, Round Rock
Novo Nordisk Investigational Site, Fresno
Novo Nordisk Investigational Site, Kanpur
Novo Nordisk Investigational Site, Bangalore
Novo Nordisk Investigational Site, Mangalore
Novo Nordisk Investigational Site, Belagavi
Novo Nordisk Investigational Site, Thiruvanathapuram
Novo Nordisk Investigational Site, Bhubaneswar
Novo Nordisk Investigational Site, Waterbury
Novo Nordisk Investigational Site, Des Moines
Novo Nordisk Investigational Site, Waltham
Novo Nordisk Investigational Site, Nashua
Novo Nordisk Investigational Site, Osijek
Novo Nordisk Investigational Site, Antibes
Novo Nordisk Investigational Site, Ahmedabad
Novo Nordisk Investigational Site, Pune
Novo Nordisk Investigational Site, Gdansk
Novo Nordisk Investigational Site, Tychy
Novo Nordisk Investigational Site, Warsaw
Novo Nordisk Investigational Site, Wroclaw
Novo Nordisk Investigational Site, Busan
Novo Nordisk Investigational Site, Daegu
Novo Nordisk Investigational Site, Seoul
Novo Nordisk Investigational Site, Seoul
Novo Nordisk Investigational Site, Seoul
Novo Nordisk Investigational Site, Sungnam
Novo Nordisk Investigational Site, Ängelholm
Novo Nordisk Investigational Site, Dalby
Novo Nordisk Investigational Site, Gothenburg
Novo Nordisk Investigational Site, Härnösand
Novo Nordisk Investigational Site, Stockholm
Novo Nordisk Investigational Site, Istanbul
Lead Sponsor
Novo Nordisk A/S
INDUSTRY